Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nirsevimab PhII/III trial confirms safety profile

28 June 2021 07:00 BST Nirsevimab MEDLEY Phase II/III trial demonstrated favourable safetyand tolerability profile in infants at high risk of RSV Nirsevimab is being developed as a passive immunisation against RSV for all infants The MEDLEY Phase II/III trial evaluated the safety and tolerability of nirsevimab compared to Synagis (palivizumab) when given to infants at high risk of respiratory syncytial virus (RSV) entering their first RSV season.[1] The trial assessed the safety of nirsevimab in infants with chronic lung disease (CLD), congenital heart disease (CHD) and/or

Embracer Group AB secures an unsecured multicurrency revolving credit facility of SEK 6.0 billion

Embracer Group AB secures an unsecured multicurrency revolving credit facility of SEK 6.0 billion arranged by leading Nordic banks Nordea, SEB and Swedbank. The facility has a tenor of three years which may be extended by up to two years and refinances in total SEK 4.4 billion in facilities with Nordea maturing in July, 2021 and May, 2022.The terms and conditions for the new facility has been improved, including a lower credit margin for utilized debt. The existing relationships with about a dozen international banks on operating group level will be maintained in addition to the facility.

YIT and NREP have agreed on the implementation of rental housing projects in Poland valued at nearly EUR 100 million

YIT Corporation Investor News 28 June 2021 at 09:00 a.m.YIT and NREP, the leading real estate investor and developer in the Nordic countries, have agreed on the construction of rental housing projects in Poland. The agreement concerns just over 1,000 apartments and its value is approximately EUR 100 million. The agreement will be added to the order book for the third quarter of 2021.  “Our strategic objective is to accelerate the development of multi-phase area projects by implementing some of the project phases as rental housing projects in cooperation with institutional investors.

Skanska invests about SEK 540M in a logistics facility in Helsingborg, Sweden

Skanska invests about SEK 540M in a logistics facility in Helsingborg, Sweden, which is fully let to Greenfood. The construction contract is worth about SEK 400M, which will be included in the Swedish order bookings for the second quarter 2021.Långeberga is a strategic logistics location in Helsingborg, just adjacent to the E4 / E6 / E20 junction that connects Copenhagen with Oslo and Stockholm. The 44,000-square meter facility will have a strong environmental focus in everything from material selection to efficient cooling systems and modern heat recovery. In addition, a solar cell system

Invitation to Electrolux Professional AB Q2 2021 presentation

Electrolux Professional AB will publish the Q2 2021 interim report for the period April – June 2021, on Thursday, July 22, at 08:00 CET.A telephone conference will be held at 09:00 CET with Alberto Zanata, CEO and Fabio Zarpellon, CFO presenting the result, followed by a Q&A session. The presentation will be available on https://www.electroluxprofessional.com/corporate/.Please use the following dial-in details to participate in the telephone conference: Sweden: +46 8 519 993 83 United Kingdom: +44 333 300 9274 United States: +1 631 913 1422 PIN: 71597406# Please note the pin

Telephone conference 16 July in connection with Interim report

The Interim report January-June 2021 will be released on Friday 16 July around 07.00 CEST.At 09.00 CEST a telephone conference will be held, participant connection: UK: +44 333 300 9032, SE: +46 8 566 426 92, US: +1 631 913 1422 PIN for US: 61959798#. The telephone conference will be webcasted live at www.ratos.com where presentation material will be available as soon as the report is released. The telephone conference will be recorded and available at www.ratos.com. For further information, please contact:Jonas Ågrup, CFO+46 70 626 01 83jonas.agrup@ratos.com About Ratos:

LeoVegas quarterly dividend

At the Annual General Meeting on 11 May 2021, it was decided that the dividend of SEK 1.60 would be paid out four times with SEK 0.40 per share. The first payment was distributed on 19 May 2021. The second payment will be paid on July 12, 2021. FOR FUTURE DISTRIBUTIONS, THE FOLLOWING APPLIES: Dividend Last trading day with Record Distribution date Amount (SEK) no. dividend entitlement date PAID DIVIDEND 1 11 May 2021 14 May 19 May 2021 0.4

Orkla acquires New York Pizza

Orkla has entered into an agreement to purchase 75% of the shares in New York Pizza, one of the leading pizza chains in the Netherlands.Last year, New York Pizza sold 11.5 million pizzas and had total turnover of EUR 54.7 million (including dough manufacturing turnover), equivalent to approximately NOK 555 million. Chain sales have increased by approx. 12 % p.a. since 2008, driven by like-for-like growth and roll-out of new sales outlets. Orkla has entered into an agreement to purchase 75% of the shares in New York Pizza. The current shareholders will continue to have an ownership of 25%.

BONHEUR ASA ANNOUNCES FIXED INCOME INVESTOR MEETINGS

Bonheur ASA (the "Company") has mandated DNB Markets and Pareto Securities as Joint Lead Managers to arrange a series of fixed income investor meetings commencing on Monday, June 28. A NOK denominated 5-year senior unsecured green bond issue may follow, subject to, inter alia, market conditions. An updated Company presentation is attached. For further information, please contact: Haakon Magne Ore, Fred. Olsen & Co., +47 92 02 75 10, hmore@fredolsen.com, orØyvind Engesrønning, Fred. Olsen & Co., +47 94 36 72 89, oyvind.engesronning@fredolsen.com

Financial Calendar 2021

Company announcement no. 7/2021 With reference to the prospectus as published by Aquaporin A/S, CVR no. 28315694, (“Aquaporin” or the “Company”) in connection with the initial public offering and admission to trading and official listing of Aquaporin’s shares on Nasdaq Copenhagen A/S on 14 June 2021 and the results announcement published on 28 June 2021, Aquaporin publishes its financial calendar for 2021: Interim report for the period ending 26 August 202130 June2021...........................Trading statement for the period 25 November 2021ending 30 September 2021..

Stabilization period begins

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFULThis announcement does not constitute a prospectus as defined by Regulation (EU) No. 2017/1129 of 14 June 2017 and nothing herein shall be construed as an offering of securities. No one should purchase or subscribe for any securities in Aquaporin A/S except on the basis of information in the prospectus published by Aquaporin A/S in connection with

Skanska builds distribution facility in Maspeth, New York, USA, for USD 110M, about SEK 930M

Skanska has signed a contract with FedEx Ground to construct a new distribution facility in Maspeth, New York, USA. The contract is worth USD 110M, about SEK 930M, which will be included in the US order bookings for the second quarter 2021.The contract includes paving, the abatement and demolition of three unoccupied buildings and the construction of a new 28,000 square meter two-story distribution facility in Maspeth, Queens. The building will feature administrative office space on the ground level and a precast concrete access ramp for second-level employee parking. The exterior precast

SBB announces the results of the invitation to Noteholders to exercise their Noteholder Voluntary Conversion Right in respect of the SEK 2.75 billion Subordinated Mandatory Convertible Notes due 2023

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES OF THE SECURITIES WOULD BE PROHIBITED BY APPLICABLE LAW OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES Stockholm, 28 June 2021 – Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB” or the “Offeror”) announces the results of the invitation (the "Invitation") to holders (the “Noteholders”) to exercise their Noteholder Voluntary Conversion Right as defined in, and in accordance with the terms and conditions (the “Conditions”) of the

Targovax to present at the 4th Annual Next Gen Immuno-Oncology Virtual Congress-US Edition

Oslo, 28 June 2021 – Targovax ASA, today announces that Victor Levitsky, Chief Scientific Officer of Targovax, is invited to present at the 4th Annual Next Gen Immuno-Oncology Virtual Congress-US Edition. 4th Annual Next Gen Immuno-Oncology Virtual Congress-US Edition, virtualDate: 29 June 2021Presenter: Victor Levitsky (CSO)Time: 14:15 EDT / 20:15 CETTitle: Clinical efficacy and immuno-modulatory properties of oncolytic adenovirus ONCOS-102   ***

UROS eSIM connectivity enables always connected experience for OnLogic Industrial and Rugged Computers

June 28[th], 2021 - Atlanta.  UROS, the global connectivity and IoT solution provider, is supplying the eSIM solution for OnLogic's line of Industrial and Rugged computers , including the latest additions to their advanced Helix and Karbon Series, which will begin shipping to business customers in Q3 2021. OnLogic, known for their highly-configurable, solution-focused computers engineered for reliability at the IoT edge, chose the UROS Connect eSIM solution because of its ability to support an easy and seamless activation of mobile subscriptions for

Invitation to Nixu Corporation’s news conference and webcast on H1 2021 financial results

Nixu Corporation Press release, June 28, 2021 at 8.00 AM EESTCybersecurity company Nixu will publish its half-year financial report for January–June 2021 on Thursday, August 12, 2021 at 8:30 AM EEST. The stock exchange release and the related presentation material will be available then on the company’s website www.nixu.com/investors. News conference A news conference will be available for analysts, investors and media on Thursday, August 12, 2021 at 9:30 AM EEST at Scandic Simonkenttä, Simonkatu 9, Helsinki. The review of H1 2021 will be presented by Nixu CEO Petri Kairinen. The

BERGENBIO TO PRESENT AT 4th ANNUAL NEXT GEN IMMUNO-ONCOLOGY VIRTUAL CONGRESS

Bergen, Norway, 28 June 2021 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, is pleased to announce that Prof. Hani Gabra MD PhD, Chief Medical Officer of BerGenBio, will deliver a virtual presentation at the 4th Annual Next Gen Immuno-Oncology Congress, which is taking place virtually from 28 June – 1 July 2021. Prof. Gabra will discuss the important role of AXL kinase in regulation of immune suppression in the tumour microenvironment. As part of the presentation, Prof Gabra will

Veidekke ASA: To build Nordic Ecolabelled massive-wood homes for OBOS in Sigtuna, Sweden

Veidekke has been commissioned by OBOS to build 53 Nordic Ecolabelled residential units in Sigtuna, northwest of Stockholm. The project is a design and build contract valued at approx. SEK 101 million, with occupancy expected to start in Q1 2023.“We are pleased to announce that the project is starting up,” says Tommy Waldnert, property developer at OBOS. “While industrial factory production is the OBOS norm, this project required a different type of construction to meet specific noise requirements. With a department dedicated to wood construction, Veidekke fulfilled an important

Hexagon Purus accelerates its efforts in the zero emission maritime segment

Hexagon Purus (HPUR), a leading global supplier of zero emission mobility technology and equipment, is accelerating its commercial efforts to bring zero emission technology to the maritime industry. Although the business has global ambitions, the main focus from the onset will be Norway – a nation with some of the strongest maritime technology industries in the world. Hexagon Purus Maritime AS has been established and the company is actively recruiting from the maritime and hydrogen industries to expand its maritime team. “We are passionate about unlocking the potential of zero

Magnolia Bostad acquires land in Sundsvall

Magnolia Bostad has signed an agreement with Diös Fastigheter for the acquisition of land in Sundsvall for the development of around 350 residential units of about 21,000 m[2] GFAThe property, which is located in the Alliero area in central Sundsvall, has a zoning plan in force and the acquisition will take place through a corporate transaction. “Together with Sundsvall municipality, we have developed a zoning plan that has come into force. This means that we can continue to create growth by enabling more people to live and work in Sundsvall. We have a good collaboration with Magnolia

Biosergen’s groundbreaking antifugal drug BSG005 is granted Orphan Drug status in the United States

Sunday, June 27, 2021: Biosergen  AB (“Biosergen” or the “Company”) today announced that the United States Food and Drug Administration (the “FDA”) has granted BSG005, the Company’s groundbreaking antifungal drug of the polyene macrolide class, Orphan Drug status in the United States. Orphan Drug status confers a number of important advantages including an expedited regulatory path and prolonged market exclusivity.Biosergen’s CEO Peder M. Andersen comments: “This is an important milestone for BSG005 and Biosergen. In addition to increasing the commercial value of the project the orphan

Camurus announces PDUFA date for Brixadi for the treatment of opioid use disorder in the US

New PDUFA action date for Brixadi set for 15 December 2021 Lund, Sweden — 26 June 2021 — Camurus (NASDAQ STO: CAMX) announced today that the New Drug Application (NDA) by Camurus’ US licensee Braeburn for Brixadi™ (buprenorphine) extended-release weekly and monthly injection for subcutaneous use for moderate to severe opioid use disorder was accepted for review by the US Food and Drug Administration (FDA). The Prescription Drug User Fee Act (PDUFA) action date is set for 15 December 2021. “We are pleased that the FDA has accepted Braeburn’s updated new drug application for Brixadi. We

CELLINK has entered into an agreement to acquire Discover Echo Inc., an innovative and revolutionary microscopy company

CELLINK AB (publ) ("CELLINK") has entered into an agreement with the shareholders of Discover Echo Inc. ("Discover Echo") to acquire all outstanding shares, on a cash- and debt-free basis, and under the assumption that the working capital at closing equals the normalized working capital, to a purchase price of USD 110 million (the "Acquisition"). Approximately eleven percent of the purchase price will be paid in newly issued shares of series B in CELLINK (the “Consideration Shares”) and the remaining part will be paid cash. CELLINK’s Board of Directors will resolve to issue the

FREYR Appoints Global Head of Investor Relations

NEW YORK, NY and OSLO, Norway, June 25, 2021 – FREYR AS (FREYR), the Norway-based developer of clean, next-generation battery cell production capacity is pleased to announce the appointment of Jeff Spittel as VP of Investor Relations to lead global shareholder engagement as the company executes its growth strategy founded on rapid scaling of clean, next-generation and low-carbon battery cell production. On January 29, 2021, FREYR announced that it plans to become a publicly listed company through a business combination with Alussa Energy Acquisition Corp. (Alussa Energy) (NYSE: ALUS).

There are no items matching the current filter
There are no more items matching the current filter
Back to top